Nucleoside diphosphate kinase as protein histidine kinase.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 153, doi. 10.1007/s00210-014-1003-3
- By:
- Publication type:
- Article
Works matching IS 00281298 AND DT 2015 AND VI 388 AND IP 2
Results: 15
1
2
Clues to the functions of plant NDPK isoforms.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 119, doi. 10.1007/s00210-014-1009-x
- By:
- Publication type:
- Article
3
Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 199, doi. 10.1007/s00210-014-1010-4
- By:
- Publication type:
- Article
4
Nme family of proteins-clues from simple animals.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 133, doi. 10.1007/s00210-014-1017-x
- By:
- Publication type:
- Article
5
The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 225, doi. 10.1007/s00210-014-1027-8
- By:
- Publication type:
- Article
6
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 257, doi. 10.1007/s00210-014-1035-8
- By:
- Publication type:
- Article
7
Regulation of the metastasis suppressor Nm23-H1 by tumor viruses.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 207, doi. 10.1007/s00210-014-1043-8
- By:
- Publication type:
- Article
8
Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 189, doi. 10.1007/s00210-014-1046-5
- By:
- Publication type:
- Article
9
Mitochondrial NM23-H4/NDPK-D: a bifunctional nanoswitch for bioenergetics and lipid signaling.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 271, doi. 10.1007/s00210-014-1047-4
- By:
- Publication type:
- Article
10
Janus-faces of NME-oncoprotein interactions.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 175, doi. 10.1007/s00210-014-1062-5
- By:
- Publication type:
- Article
11
Evidence of histidine and aspartic acid phosphorylation in human prostate cancer cells.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 161, doi. 10.1007/s00210-014-1063-4
- By:
- Publication type:
- Article
12
Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 243, doi. 10.1007/s00210-014-1066-1
- By:
- Publication type:
- Article
13
Inhibition of telomerase activity by NME2: impact on metastasis suppression?
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 235, doi. 10.1007/s00210-014-1077-y
- By:
- Publication type:
- Article
14
Progress on Nme (NDP kinase/Nm23/Awd) gene family-related functions derived from animal model systems: studies on development, cardiovascular disease, and cancer metastasis exemplified.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
15
Interaction between Nm23 and the tumor suppressor VHL.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 2, p. 143, doi. 10.1007/s00210-014-1002-4
- By:
- Publication type:
- Article